Cargando…
Minimal change disease with thrombotic microangiopathy following the Pfizer-BioNTech COVID-19 vaccine
Autores principales: | Tanaka, Fumika, Katayama, Kan, Joh, Kensuke, Tsujimoto, Kayo, Yamawaki, Masahiro, Saiki, Ryosuke, Kurita, Tairo, Murata, Tomohiro, Dohi, Kaoru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767873/ https://www.ncbi.nlm.nih.gov/pubmed/35198160 http://dx.doi.org/10.1093/ckj/sfab234 |
Ejemplares similares
-
A Perihilar Variant of Focal Segmental Glomerulosclerosis Due to De novo Branchio-oto-renal Syndrome
por: Saiki, Ryosuke, et al.
Publicado: (2021) -
Immune-mediated thrombotic thrombocytopenic purpura following administration of Pfizer-BioNTech COVID-19 vaccine
por: Giuffrida, Gaetano, et al.
Publicado: (2021) -
Three Weeks of Treatment Induced Long-term Remission in a Patient with Micrococcus luteus-related Peritonitis
por: Saiki, Ryosuke, et al.
Publicado: (2022) -
Disruption of the glomerular basement membrane associated with nutcracker syndrome and double inferior vena cava in Noonan syndrome: a case report
por: Omori, Ayumi, et al.
Publicado: (2022) -
Myocarditis with Pfizer-BioNTech's COVID-19 vaccine in Israel
Publicado: (2021)